1. Home
  2. INDB vs NUVB Comparison

INDB vs NUVB Comparison

Compare INDB & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Independent Bank Corp.

INDB

Independent Bank Corp.

HOLD

Current Price

$76.39

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$5.84

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDB
NUVB
Founded
1907
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
2.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
INDB
NUVB
Price
$76.39
$5.84
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$75.20
$10.44
AVG Volume (30 Days)
331.3K
6.3M
Earning Date
01-22-2026
03-05-2026
Dividend Yield
3.09%
N/A
EPS Growth
N/A
N/A
EPS
4.05
N/A
Revenue
$712,224,000.00
$26,748,000.00
Revenue This Year
$33.63
$616.63
Revenue Next Year
$20.70
$202.59
P/E Ratio
$18.89
N/A
Revenue Growth
8.60
1137.19
52 Week Low
$52.15
$1.54
52 Week High
$78.17
$9.75

Technical Indicators

Market Signals
Indicator
INDB
NUVB
Relative Strength Index (RSI) 57.64 27.65
Support Level $73.15 $6.07
Resistance Level $77.43 $6.63
Average True Range (ATR) 1.69 0.53
MACD -0.01 -0.42
Stochastic Oscillator 81.40 1.79

Price Performance

Historical Comparison
INDB
NUVB

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: